ADVANCED COLORECTAL CANCER
Clinical trials for ADVANCED COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to outperform standard therapy for advanced colorectal cancer
Disease control Not yet recruitingThis phase 3 trial tests whether adding the experimental drug SHR-A1811 to standard chemotherapy and bevacizumab works better than standard therapy alone for people with advanced colorectal cancer who have not had prior treatment. About 300 participants will receive either the ne…
Matched conditions: ADVANCED COLORECTAL CANCER
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Cottonseed compound plus immunotherapy takes on tough colorectal cancer
Disease control Not yet recruitingThis phase 2 trial tests whether combining sintilimab (an immunotherapy) with gossypol acetate (a compound from cottonseed) can shrink tumors in people with advanced colorectal cancer that has not responded to at least two prior treatments. The study will enroll 32 adults aged 18…
Matched conditions: ADVANCED COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug cocktail hopes to tackle advanced colon cancer
Disease control Not yet recruitingThis study tests a new drug called HDM2017 combined with standard treatment (fruquintinib) in 120 people with advanced colorectal cancer that has spread. The goal is to find the safest dose and see if the combination can shrink tumors. Participants must have tried other treatment…
Matched conditions: ADVANCED COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug cocktail targets Hard-to-Treat gut cancers
Disease control Not yet recruitingThis Phase 2 trial tests a combination of tunlametinib and anti-EGFR antibodies (cetuximab β or nimotuzumab) in 90 adults with advanced colorectal or pancreatic cancers that have RAS mutations and have not responded to standard treatments. The goal is to see if the combo shrinks …
Matched conditions: ADVANCED COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can an amino acid boost chemo? early trial launches for advanced colorectal cancer
Disease control Not yet recruitingThis early-stage trial is testing whether adding oral serine, a natural amino acid, to standard chemotherapy is safe for people with advanced colorectal cancer. The study will enroll 20 adults who are eligible for first-line treatment with fluorouracil-based drugs. The main goal …
Matched conditions: ADVANCED COLORECTAL CANCER
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 26, 2026 17:33 UTC